UK markets closed

Gossamer Bio, Inc. (GOSS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7422+0.0094 (+1.28%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
129,901
135,304
170,919
170,267
160,854
Selling general and administrative
37,890
38,455
47,609
45,782
49,728
Total operating expenses
167,791
173,759
218,528
216,049
210,582
Operating income or loss
-167,791
-173,759
-218,528
-216,049
-210,582
Interest expense
13,140
13,511
13,880
19,440
12,666
Total other income/expenses net
6,597
5,456
1,447
724
-23,554
Income before tax
-172,580
-179,817
-229,378
-234,004
-243,360
Income from continuing operations
-172,580
-179,817
-229,378
-234,004
-243,360
Net income
-172,580
-179,817
-229,378
-234,004
-243,360
Net income available to common shareholders
-172,580
-179,817
-229,378
-234,004
-243,360
Basic EPS
-1.60
-1.18
-2.71
-3.13
-3.55
Diluted EPS
-1.60
-1.18
-2.71
-3.13
-3.55
Basic average shares
119,666
152,622
84,575
74,843
68,510
Diluted average shares
119,666
152,622
84,575
74,843
68,510